Title for MeetingAbstracts
Alphabetical listing of titles
Quantifying global expenditures on AIDS vaccine R&D.
Quantifying HIV infectivity.
Quantifying IFNgamma-secreting cells in exposed uninfected individuals.
QUANTIFYING PREVENTABLE MENINGITIS, LAZIO REGION, ITALY.
Quantifying recent thymic emigrants (RTE) in blood and tonsils of HIV-1-infected patients before and after HAART with a real-time PCR assay for T-cell receptor excisional circles (TREC).
Quantifying recent thymic emigrants (RTE) in blood of >400 normal persons with a real-time PCR/ molecular beacon assay for T-cell receptor (TCR) excisional circles (TREC).
Quantifying residual HIV-1 replication and decay of the latent reservoir in patients on seemingly effective combination antiretroviral therapy.
Quantifying the reduction in risk for HIV infection by choice of partner, sex act and condom use.
Quantifying utilities: methodological aspects of preference-based quality of life measurement in economic evaluation of health technologies.
QUANTITATING HIV DNA FROM REVERSE TRANSCRIPTION TO INTEGRATION IN VIVO.
Quantitating the HIV-1 specific cytotoxic T cell response.
Quantitation and anti-viral effect of unbound plasma indinavir (IDV) in HIV-infected persons.
Quantitation and modulation of HIV P24 antigen content in intestinal mucosa.
Quantitation and prevalence of HIV RNA in Japanese HIV carriers and AIDS patients.
Quantitation and temporal viability of Human Immunodeficiency Virus type 1 in peritoneal dialysate.
Quantitation by competitive PCR of HIV-1 proviral DNA in epidermal Langerhans cells of HIV-infected patients.
Quantitation by Intracellular Cytokine Detection of Memory CD4+ T-Cell Frequencies for Varicella-Zoster Virus, Herpes Simplex Virus, and Human Cytomegalovirus after Natural Infection or Varicella Immunization.
Quantitation of 3'-amino-3'-deoxythymidine (AMT), a toxic catabolite of 3'-azido-3'-deoxythymidine (AZT), by competitive ELISA.
Quantitation of antibody reactivity to HIV-1 proteins and glycoproteins on Western blots by scanning densitometry.
Quantitation of antimycobacterial antibodies to A60 antigen in HIV infected individuals.
Quantitation of AZT resistant viruses in the HIV cohort at the Royal London Hospital.
QUANTITATION OF BLOOD LYMPHOCYTE MITOCHONDRIAL DNA FOR THE MONITORING OF ANTIRETROVIRAL DRUG-INDUCED MITOCHONDRIAL DNA DEPLETION.
Quantitation of candida albicans in the oropharynx of asymptomatic HIV-infected males and patients with oropharyngeal candidiasis.
Quantitation of CD4 and CD8 T-Cell Proliferation to Soluble Antigens and Inactivated HIV-1 by Flow Cytometry in Various Stages of Disease.
Quantitation of cellular HIV-1 DNA load during the six first years following HIV infection: a prospective study.
Quantitation of cerebral edema using image analysis.
QUANTITATION OF CMV DNA BY REAL-TIME PCR IN PLASMA FOR PREDICTION OF OCCURRENCE OF CMV DISEASE IN HIV-INFECTED PATIENTS RECEIVING HIGHLY ACTIVE ANTIRETROVIRAL THERAPY IN THE PREDIVIR ANRS COHORT.
Quantitation of CRF01-AE isolates by real time PCR with a newly designed probe in the LTR region.
Quantitation of cytomegalovirus (CMV) in cerebrospinal fluid (CSF) in AIDS patients by polymerase chain reaction (PCR).
Quantitation of cytomegalovirus (CMV) load in blood fractions of patients with AIDS: comparative study of different laboratory methods.